CTIS.eu › Drugs › Pneumococcal Polysaccharide Serotype 33F Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 22F Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 9N Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 8 Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 12F Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 20 Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 17F Conjugated To Crm197, Abc-15Bo-116, Abc-15A-116, Abc-16F-116, Abc-23A-116, Abc-24F-116, Abc-23B-116, Abc-31-116, Abc-35B-116, Pneumococcal Polysaccharide Serotype 3 Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 6A Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 7F Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 19A Conjugated To Crm197

Pneumococcal Polysaccharide Serotype 33F Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 22F Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 9N Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 8 Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 12F Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 20 Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 17F Conjugated To Crm197, Abc-15Bo-116, Abc-15A-116, Abc-16F-116, Abc-23A-116, Abc-24F-116, Abc-23B-116, Abc-31-116, Abc-35B-116, Pneumococcal Polysaccharide Serotype 3 Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 6A Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 7F Conjugated To Crm197, Pneumococcal Polysaccharide Serotype 19A Conjugated To Crm197

3 trials

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

1 Sponsors

6 Countries

Phase III

Phase III: 3

Indications tested

Pneumococcal infection 1

Sponsors using this IMP

Merck Sharp & Dohme LLC 3

All trials

3 total

Safety and Immunogenicity of V116 in Children and Adolescents With Increased Risk for Pneumococcal Disease Ended

2023-506236-32-00 Phase III 5 countries Merck Sharp & Dohme LLC
A clinical study of the V116 vaccine for adults who have an increased risk for invasive pneumococcal disease Ended

2022-502791-22-01 Phase III 1 country Merck Sharp & Dohme LLC
Safety and Immunogenicity of V116 in Adults 50 Years of Age or Older Ended

2022-503144-40-00 Phase III 2 countries Merck Sharp & Dohme LLC

Showing 1–3 of 3 trials

← All drugs A–Z